UPDATE: Abstract acceptances have been emailed; if you didn't receive a confirmation, please contact us right away: adai@uw.edu

Priority Areas

  • Changing Landscapes, Changing Policies:
    This theme may include issues related to evolving policies on marijuana legalization and/or policing, medication assisted treatment, harm reduction (e.g. access to needle exchange or safe injection sites), naloxone distribution and training, etc.
  • Integration of Addiction Medicine:
    This theme concerns issues related to the integration of addiction treatment and primary health care, addiction services in non-health settings, care coordination models, implementation strategies, and the impact of the ACA on treatment for substance use disorders.
  • Health Disparities & Equities:
    This theme concerns issues related to treatment access, quality and outcomes for diverse populations.
  • Co-occurring Substance Use & Infectious Disease:
    This priority area concerns issues of prevention and treatment of co-occurring substance use with HIV/AIDS, HCV and other infectious diseases.


Acceptance and Notification

Acceptance of abstracts into the Conference program will be determined by scientific merit and relevance. Preference will be given to presentations that report new results of research. Presenters will be asked to indicate a preference for oral or poster presentation, however the committee will determine the presentation method. Abstract acceptances have been emailed; if you didn't receive a confirmation, please contact us right away: adai@uw.edu


All presenters of accepted abstracts are required to register and attend the conference.

The deadline for Early Bird registration is September 1, 2016.

Early Career Investigator Awards

Pending the availability of funds, a limited number of awards may be available to support conference attendance of early career investigators interested in addiction health services research. These awards would provide up to $1000 to cover conference attendance costs (transportation, lodging, registration). Eligible candidates must be no more than 5 years removed from their terminal research degree; not have served as PI on an NIH R01 or equivalent research grant; not have previously received an AHSR new investigator award; and must be the presenting author on an accepted oral or poster presentation at AHSR 2016.  Qualified attendees should indicate their interest in being considered for these awards on the abstract submission form. 

For questions or technical difficulties, email adai@uw.edu.

Alcohol and Drug Abuse Institute University of WashingtonNW Addiction Technology Transfer Center